Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02838511 · ClinicalTrials.gov registry record

Measure of Frailty in Perioperative Setting

A clinical trial of Frailty, sponsored by The Cleveland Clinic.

Completed
Registry status
1,190
Enrollment target
1
Study location

NCT02838511: Completed study of Frailty, sponsored by The Cleveland Clinic.

NCT02838511 is a study of Frailty that has completed, run by The Cleveland Clinic. The registered enrollment target is 1,190 participants, below the 1,481-participant average among 48 other Frailty trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02838511, a study of Frailty, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
1,190 participants
Enrollment target
1
Study location

Study Summary

Though most physicians believe they can identify frail patients, frailty is a poorly characterized and complex clinical syndrome. Frailty has been categorized four dimensions by de Vries et al: 1) physical (physical activity, nutrition, mobility, strength and energy); 2) biochemical (nutritional and inflammatory biomarkers); 3) psychological (cognition and mood); and, 4) social (social contact and support). 1 However, the pathophysiology of frailty remains unclear. Two broad hypotheses have been proposed. Deficit accumulation model: This hypothesis assumes that frailty occurs due to accumulation and additive effect of multiple deficits, which occur across various domains. The more deficits a person has, the more likely that person is to be frail. Frailty in this paradigm is thus measured by identifying the number of positive factors/ deficits from a list. This is used to create a proportional index of deficits, expressed as the ratio of deficits present to the total number of deficits considered. Many studies have used a modified frailty index (MFI) with 11 factors, which has shown to correlate well with patient outcomes after surgery. Phenotype model: Fried et al in 2001 proposed a phenotype based model, in which she identified various clinical features that define frailty as a clinical syndrome. This criterion, known as Fried index, consists of 5 factors- shrinking, weakness, exhaustion, slowness, and low physical activity level. The Fried index is the most commonly used phenotype-based assessment tool to evaluate frailty. An advantage is its ease-of use during preoperative visits. Measurement of these factors in a perioperative setting was further characterized by Makary et al in 2010, and was the basis for the Hopkins Frailty Score (HFS). Currently, there exists no gold standard for assessment of frailty, especially in the perioperative setting. In the absence of a well-accepted gold standard, a measurement of frailty which would predict adverse postoperativ

Primary Outcome

total number of days spent by patient in the hospital within 30 days of non-cardiac surgery

Conditions Studied

Interventions

  • OTHER Modified Frailty Index (MFI)
  • OTHER Hopkins Frailty Score (HFS)

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 1,190 participants
Start Date 2015-01
Est. Completion 2019-09
The Cleveland Clinic

688 total trials

What the finished NCT02838511 record still lists

NCT02838511 is an observational study that tracks outcomes without assigning an intervention. Its 1,190 participants enrollment target places it among the larger protocols in the corpus, below the 1,481-participant average among 48 other Frailty trials with a reported enrollment target (20% lower).

The record links to 1 condition, with Frailty appearing as the primary indexed condition, and to 2 interventions - of which Modified Frailty Index (MFI) is the first listed.

NCT02838511 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02838511 about?

NCT02838511 is a clinical study titled "Measure of Frailty in Perioperative Setting". Though most physicians believe they can identify frail patients, frailty is a poorly characterized and complex clinical syndrome. Frailty has been categorized four dimensions by de Vries et al: 1) physical (physical activity, nutrition, mobility, strength and energy); 2) biochemical (nutritional and...

What is the current status of trial NCT02838511?

This trial is currently completed. The enrollment target is 1,190 participants. The study started on 2015-01. Estimated completion is 2019-09.

What conditions does trial NCT02838511 study?

This clinical trial studies the following conditions: Frailty.

What interventions are being tested in trial NCT02838511?

The interventions under investigation include: Modified Frailty Index (MFI) (OTHER), Hopkins Frailty Score (HFS) (OTHER).

Who is sponsoring clinical trial NCT02838511?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02838511 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Frailty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02838511's enrollment target sits among peer trials

1,190 5th of 48 higher than 44 of 48 other Frailty trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Frailty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05580419 · 1,188 participants · NA

    Impact of 4PCP on Practitioner and Patient Outcomes

  • NCT06290869 · 1,188 participants · Phase 3

    Tobacco Education and Lung Health Study (TEAL)

  • NCT04293562 · 1,186 participants · Phase 3

    A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  • NCT07177339 · 1,196 participants · Phase 3

    eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02838511, the US trial registry maintained by the National Library of Medicine. NCT02838511 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.